Good thread here and note the author is not an apologist for the drug pricing status quo (read his book!) but we are dealing with a situation here that is not the normal drug pricing dilemma. https://twitter.com/peterkolchinsky/status/1390681008878534660
“Normal” drug pricing is that the marginal cost of producing an extra dose is very low.

But the value to consumers of the doses is very high.

So the patent owner uses monopoly power to keep the price to consumers much higher than the marginal cost of production.
Right now mRNA vaccines are scarce even in many affluent countries that can easily afford what Pfizer & Moderna are charging — there is a genuine scarcity of doses and the marginal cost of production seems to be very high.

It’s a different kind of dilemma.
You can follow @mattyglesias.
Tip: mention @twtextapp on a Twitter thread with the keyword “unroll” to get a link to it.

Latest Threads Unrolled: